Observational studyTherapeutic advances in respiratory disease

Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study.

Angela Pepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.